SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-033709
Filing Date
2022-10-06
Accepted
2022-10-06 16:28:07
Documents
75
Period of Report
2022-08-31

Document Format Files

Seq Description Document Type Size
1 10-Q nrix-10q_20220831.htm   iXBRL 10-Q 3335465
2 EX-10.2 nrix-ex102_182.htm EX-10.2 20839
3 EX-10.3 nrix-ex103_181.htm EX-10.3 14968
4 EX-10.4 nrix-ex104_180.htm EX-10.4 23642
5 EX-10.5 nrix-ex105_179.htm EX-10.5 20095
6 EX-10.6 nrix-ex106_183.htm EX-10.6 58345
7 EX-31.1 nrix-ex311_6.htm EX-31.1 21840
8 EX-31.2 nrix-ex312_7.htm EX-31.2 21776
9 EX-32.1 nrix-ex321_8.htm EX-32.1 12871
  Complete submission text file 0001564590-22-033709.txt   10302929

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA nrix-20220831.xsd EX-101.SCH 53188
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nrix-20220831_cal.xml EX-101.CAL 50698
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nrix-20220831_def.xml EX-101.DEF 171147
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE nrix-20220831_lab.xml EX-101.LAB 418884
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nrix-20220831_pre.xml EX-101.PRE 320293
69 EXTRACTED XBRL INSTANCE DOCUMENT nrix-10q_20220831_htm.xml XML 1912552
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filer) CIK: 0001549595 (see all company filings)

IRS No.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 001-39398 | Film No.: 221298436
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences